Standard Dose Versus Myeloablative Therapy for Previously Untreated Symptomatic Multiple Myeloma, A Phase III Intergroup Study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carmustine; Cyclophosphamide; Dexamethasone; Doxorubicin; Interferon alpha; Melphalan; Prednisone; Vincristine
- Indications Multiple myeloma
- Focus Therapeutic Use
- 06 Mar 2015 Biomarkers information updated
- 02 Apr 2012 Planned end date (Oct 2030) added as reported by ClinicalTrials.gov.
- 17 May 2007 Updated from NCT (dms 13-02-2007)